Smith & Nephew is an industry leader in each of our three main Global Business Units - Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. These businesses jointly offer over 1,000 product ranges.

Our global infrastructure continues to expand each year. We currently operate in 32 countries and generate annual sales of $3.4 billion. Substantial investment in our products and intensive research and development means that we are always ahead. Figures from last year show that we stand at number one as the leading company in Arthroscopy. We are the second largest organisation in Advanced Wound Management and number three in Trauma and Clinical Therapies. We are also positioned at number four in reconstruction.

Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. This is the primary focus of our fourth business unit, Biologics.

Show more
London, GB
Size (employees)
15,000 (est)
Smith & Nephew was founded in 1856 and is headquartered in London, GB
Report incorrect company information

Key People/Management at Smith & Nephew

Olivier Bohuon

Olivier Bohuon

Graham Baker

Graham Baker

John W. Campo

John W. Campo

Helen Maye

Helen Maye

Philippe Mazas

Philippe Mazas

Group CIO

Smith & Nephew Office Locations

Smith & Nephew has offices in Austin, St. Petersburg, Memphis, Andover and in 4 other locations
London, GB (HQ)
15 Adam Street
São Paulo, BR
Av. do Café, 277
Andover, US
150 Minuteman Road
Austin, US
7000 W William Cannon Dr.
Durham, US
4721 Emperor Blvd. Suite 100
Fort Worth, US
3909 Hulen Street
Show all (8)
Report incorrect company information

Smith & Nephew Financials and Metrics

Smith & Nephew Financials

Smith & Nephew's revenue was reported to be £3.61 b in FY, 2016 which is a 13.5% increase from the previous period.

Revenue (FY, 2016)

3.6 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

2.6 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

606 m

Market capitalization (15-May-2018)

329.6 m

Closing share price (15-May-2018)


Cash (31-Dec-2016)

77.3 m
Smith & Nephew's current market capitalization is $329.6 m.
GBPFY, 2013FY, 2014FY, 2015FY, 2016


2.9 b3.2 b3.2 b3.6 b

Revenue growth, %


Cost of goods sold

724.8 m797.5 m784.4 m983.2 m

Gross profit

2.1 b2.4 b2.4 b2.6 b
GBPFY, 2013FY, 2014FY, 2015FY, 2016


90.3 m63.8 m82.4 m77.3 m

Accounts Receivable

616.1 m664.3 m644.4 m800.7 m

Current Assets

1.5 b1.7 b1.7 b2 b


825.6 m749.4 m808.5 m939.9 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash From Operating Activities

571.3 m468.7 m706.9 m656.2 m

Cash From Financing Activities

(328.1 m)691.8 m(383 m)(408.9 m)

Income Taxes Paid

(162.1 m)(146.2 m)(102.3 m)(214.9 m)
GBPY, 2016

Financial Leverage

1.9 x
Show all financial metrics

Smith & Nephew Operating Metrics

Smith & Nephew's Training Provided, no. of people was reported to be 90 k in FY, 2016.
FY, 2016

Training Provided, no. of people

90 k
Show all operating metrics
Report incorrect company information

Smith & Nephew News and Updates

Pappas Capital sells Rotation Medical to Smith & Nephew

Smith & Nephew plc has acquired Plymouth, Minnesota-based Rotation Medical, a developer of treatments for rotator cuff disease, for an initial cash consideration of $125 million. The seller was Pappas Capital.
Report incorrect company information